Post Traumatic Stress Disorder Clinical Trial
Official title:
Sudarshan Kriya Yoga (SKY) Versus Wait List Control (WLC) in Post Traumatic Stress Disorder: A Randomised Controlled Study
Patients with post traumatic stress disorder (PTSD) will be randomized to a 12-week intervention of Sudarshan Kriya Yoga Trauma Relief Program (SKY) or a wait list control (WLC) to assess the effects of this intervention on symptoms of PTSD, depression, anxiety, quality of life, autonomic symptoms, and blood inflammatory markers.
A single-center, single blind longitudinal randomized controlled naturalistic trial comparing
a 12 week Sudarshan Kriya Yoga Trauma Relief Program (SKY) intervention to a wait list
control (WLC) group.
Research participants will be men and women, 18-75 years of age, who have PTSD. The study
will recruit from the general adult ambulatory mental health clinics as well as the geriatric
mental health program in London.
Potential participants will be screened as per inclusion and exclusion criteria by trained
research staff. These patients will already have clinically diagnosed PTSD by a psychiatrist
and any other comorbid diagnoses would have already been confirmed. However, for research
purposes a diagnosis of PTSD will be confirmed through a structured clinical interview
specifically the MINI (Mini International neuropsychiatric Interview) and the
Clinician-administered PTSD Scale for DSM5- past month version (CAPS5). CAPS5 will also be
used to rule out exclusion criteria of severe depersonalization and derealization. The scales
will be administered by a trained research staff and confirmed by a psychiatrist.
The MINI will also be used to assess for suicidality. If the total score on Questions C1 and
C2 is more than 5 at any time during the study then this will be reported to the PI who will
further assess the patient for safety and risk assessment.
If the participant is above the age of 65 years of age they will also be asked to complete a
cognitive screening test (Mini Mental State Examination, MMSE) to ensure they are not
suffering from any memory impairments.
Participants who meet the inclusion criteria will be randomized to either SKY or WLC with
equal probability (1:1) using computer generated randomisation numbers. Concealment of
randomisation to outcome assessors and investigators will be ensured by an independent staff
member who will perform the randomisation using a third party web based provider.
Computerised randomization will take place in the Geriatric Mental Health Program outpatient
unit in London Health Sciences, London, Ontario. A telephone number will be available for
study concerns/queries. Pre-randomized information will be stored using unique de-identifiers
and downloaded on a secure database. It will not be possible to blind participants to
intervention status hence the single-blind design.
SKY training involves attending a week-long (6 days) course that teaches the basic principles
of SKY over 2.5-3 hour daily sessions. This will be followed by once weekly follow up
sessions (90 min/wk) for 3 weeks and then bimonthly sessions (every 2 weeks) for the next 8
weeks. In addition, participants will be asked to practice SKY at home daily (25 min/day)
throughout the duration of the study period and log practice frequency and any other
noteworthy observations in a log sheet that will be provided to them (please see attached log
sheet). Meals will be provided for 2 days during the initial SKY training course and
nutritional snacks on the other 4 days.
Participants randomized to the control arm of the study will continue to receive their
treatment as usual, including pharmacotherapy and/or psychotherapy. They will follow
assessment and study procedures as listed below. Upon completing the initial 12 weeks of the
study, participants in the WLC arm will also be offered the opportunity to learn SKY and
attend follow up therapy sessions; that is, WLC participants will be offered the same
intervention as the SKY group received in the first 12 weeks of the study. No study
procedures will be applied or any other information collected during this period except for a
final assessment that will take place at 24 weeks (see below).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Recruiting |
NCT05934175 -
Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder
|
N/A | |
Recruiting |
NCT05934162 -
Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD
|
N/A | |
Completed |
NCT04460014 -
Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT
|
N/A | |
Completed |
NCT05877807 -
Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
|
||
Active, not recruiting |
NCT05992649 -
The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject
|
N/A | |
Terminated |
NCT04404712 -
FAAH Availability in Psychiatric Disorders: A PET Study
|
Early Phase 1 | |
Not yet recruiting |
NCT05331534 -
Effect of Attentional Therapy on Post-traumatic Stress Disorder
|
N/A | |
Not yet recruiting |
NCT03649607 -
Accelerated Resolution Therapy for HIV Positive African, Caribbean and Black
|
N/A | |
Not yet recruiting |
NCT04076215 -
Biochemical and Physiological Response to Stressogenic Stimuli
|
N/A | |
Not yet recruiting |
NCT02545192 -
A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments
|
Phase 1 | |
Completed |
NCT02329418 -
Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit
|
N/A | |
Active, not recruiting |
NCT00978484 -
A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder
|
Phase 3 | |
Completed |
NCT00760734 -
Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)
|
Phase 1 | |
Completed |
NCT03278171 -
Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
|
||
Recruiting |
NCT05874362 -
People Bereaved by Violent Death : Negative Event Biases and Temporal Perception
|
N/A | |
Terminated |
NCT03898843 -
Assisted Animal Therapy: ReAnimal
|
N/A | |
Recruiting |
NCT04747379 -
Psychological Effect of Explicit Recall After Sedation (PEERS)
|
||
Completed |
NCT03248167 -
Cannabidiol as a Treatment for AUD Comorbid With PTSD
|
Phase 1/Phase 2 |